OROJIN™️ Makes Global Debut at BIOHK 2025 to Lead The Future of Preventive Medicine
Breakthrough Chewable Chlorogenic Acid Tablet Designed To Support Immunity, Cellular Vitality and Metabolism. HONG KONG SAR - Media OutReach Newswire - 15 September 2025 - OROJIN™️ , the breakthrough oral chewable tablet system was unveiled at BIOHK 2025, one of the world's most influential biotechnology gatherings. Signalling the beginning of a new era in preventive medicine, OROJIN™️ was created to redefine the way people approach their health. More than a supplement, OROJIN™️ delivers a daily dose of chlorogenic acid, a powerful antioxidant that supports immunity, cellular vitality, and promotes metabolic harmony. A "Daily Act of Self-Respect", OROJIN™️ empowers people everywhere to live stronger, healthier, and more fulfilled lives. Science That Protects Developed in collaboration with leading professors and medical pioneers from the Miskawaan Health Group (MHG) and Jiuzhang Biotech, OROJIN™️ is b...
